Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Lithium Royalty Corp. Announces 81% Growth in LCEts for 2024 in First Full Calendar Year as a Public Company; Mariana Lithium Project Inaugurated in 1Q25

In This Article:

  • LRC announces 2024 annual revenue of $3.0 million; implies 233 Lithium Carbonate Equivalent Tonnes (LCEts)1, an LCEt increase of 81% year-on-year, driven by significant volume growth in the portfolio

  • Ganfeng Lithium’s Mariana project inaugurated on February 12, 2025, supporting LRC’s 2025 revenue growth with another producing project in the LRC portfolio

  • New asset start-ups and Sigma’s Phase II expansion targeted for 2H25 to contribute to revenue growth in 2025 and 2026

  • Partial sale to Triple Flag of royalty over the Tres Quebradas Project on track to complete in 1Q25, providing C$40 million to replenish LRC’s balance sheet at cyclical lows of the lithium market

(in thousands of U.S. dollars unless otherwise noted)

TORONTO, March 17, 2025--(BUSINESS WIRE)--Lithium Royalty Corp. (TSX: LIRC) ("LRC" or the "Company") announces its fourth quarter and annual 2024 revenue results.

"Lithium Royalty Corp.’s revenue performed better than the lithium pricing indices for both the fourth quarter and calendar year 2024. This was aided by a diversified portfolio of royalties and the continued ramp up by Sigma Lithium. Sigma Lithium is one of the lowest cost lithium producers in the world and substantially grew volumes in 2024.

Our Lithium Carbonate Equivalent tonnes (LCEts) grew by 81% year-on-year in 2024, highlighting the benefits of our diversified royalty model, following an increase of 242% in 2023. This marks another consecutive year of LCEt growth for LRC despite the volatile market conditions," stated Ernie Ortiz, President and CEO of Lithium Royalty Corp.

LRC is reporting 61 LCEts or 787 Spodumene Concentrate Equivalent Tonnes (SCEts) in the quarter2, compared to 19 LCEts or 247 SCEts in the prior quarter and 37 and 451 respectively in the fourth quarter of 2023.

Financial Highlights

For the three months ended December 31,

For the year ended December 31,

2024

2023

Variance

%

2024

2023

Variance

%

Royalty revenue

620

1,013

(393)

-39%

3,024

5,522

(2,498)

-45%

Depletion

(139)

(279)

140

-50%

(585)

(935)

350

-37%

Gross profit

481

734

(253)

-34%

2,439

4,587

(2,148)

-47%

General and administrative expenses

(1,541)

(2,201)

660

(5,913)

(7,896)

1,983

Net loss for the period

(278)

(826)

548

 

(2,659)

(4,967)

2,308

 

Income tax (recovery) / expense

(848)

(653)

(195)

(1,440)

2,887

(4,327)

Finance loss/ (income)

3

(54)

57

(92)

(1,329)

1,237

Depletion

139

279

(140)

585

935

(350)

EBITDA

(984)

(1,254)

270

 

(3,606)

(2,474)

(1,132)

 

Foreign exchange loss / (gain)

3

(44)

47

45

(1,161)

1,206

One-time share-based compensation

104

603

(499)

748

2,009

(1,261)

One-time IPO costs

-

-

-

-

869

(869)

Impairment expense

-

-

-

1,063

-

1,063

Other non-recurring (income) loss

-

-

-

(750)

37

(787)

Exploration costs

-

-

-

-

414

(414)

Adjusted EBITDA

(877)

(695)

(182)

 

(2,500)

(306)

(2,194)

 

Royalty revenue decreased 39% from $1.0 million to $0.6 million for the three months ended December 31, 2024, compared to the same period last year, and $3.0 million for the full fiscal 2024 year as compared to $5.5 million in 2023, or 45% on a year-over-year basis. The decline in royalty revenue is largely attributable to lower realized prices in 2024, compared to 2023. Average spodumene prices declined by 76% year-over-year as reported by Benchmark Minerals. The average spodumene concentrate price CIF China in 2024 was $933/tonne, compared to $3,919/tonne in 2023.